Purinergic Signaling and the Immune Response in Sepsis: A Review.

[1]  D. Angus,et al.  Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. , 2016, American journal of respiratory and critical care medicine.

[2]  N. Shapiro,et al.  Mitochondrial Dysfunction, Depleted Purinergic Signaling, and Defective T Cell Vigilance and Immune Defense. , 2016, The Journal of infectious diseases.

[3]  G. Núñez,et al.  Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock. , 2015, Immunity.

[4]  W. Junger,et al.  mTOR and differential activation of mitochondria orchestrate neutrophil chemotaxis , 2015, The Journal of cell biology.

[5]  W. Junger,et al.  Inhibition of Neutrophils by Hypertonic Saline Involves Pannexin-1, CD39, CD73, and Other Ectonucleotidases , 2015, Shock.

[6]  G. Bearman,et al.  Early goal-directed resuscitation of patients with septic shock: current evidence and future directions , 2015, Critical Care.

[7]  M. Idzko,et al.  Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  S. Opal,et al.  Sepsis: a roadmap for future research. , 2015, The Lancet. Infectious diseases.

[9]  C. Takiya,et al.  The P2X7 Receptor Contributes to the Development of the Exacerbated Inflammatory Response Associated with Sepsis , 2015, Journal of Innate Immunity.

[10]  S. Robson,et al.  CD39 improves survival in microbial sepsis by attenuating systemic inflammation , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  G. Burnstock,et al.  Purinergic signalling and immune cells , 2014, Purinergic Signalling.

[12]  W. Junger,et al.  Mitochondria Regulate Neutrophil Activation by Generating ATP for Autocrine Purinergic Signaling* , 2014, The Journal of Biological Chemistry.

[13]  W. Junger,et al.  Plasma ATP is Required for Neutrophil Activation in a Mouse Sepsis Model , 2014, Shock.

[14]  N. Shapiro,et al.  Mitochondria Are Gate-keepers of T Cell Function by Producing the ATP That Drives Purinergic Signaling* , 2014, The Journal of Biological Chemistry.

[15]  G. Escobar,et al.  Hospital deaths in patients with sepsis from 2 independent cohorts. , 2014, JAMA.

[16]  P. Pickkers,et al.  Alkaline phosphatase: a possible treatment for sepsis-associated acute kidney injury in critically ill patients. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  M. Idzko,et al.  Nucleotide signalling during inflammation , 2014, Nature.

[18]  Kai Zhang,et al.  Alarmin HNP-1 promotes pyroptosis and IL-1β release through different roles of NLRP3 inflammasome via P2X7 in LPS-primed macrophages , 2014, Innate immunity.

[19]  P. Brouckaert,et al.  Extracellular ATP drives systemic inflammation, tissue damage and mortality , 2014, Cell Death and Disease.

[20]  R. Beale,et al.  Depletion of blood neutrophils from patients with sepsis: treatment for the future? , 2013, International immunopharmacology.

[21]  J. Köhl,et al.  C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. , 2013, Blood.

[22]  T. van der Poll,et al.  Severe sepsis and septic shock. , 2013, The New England journal of medicine.

[23]  W. Junger,et al.  Pannexin 1 Channels Link Chemoattractant Receptor Signaling to Local Excitation and Global Inhibition Responses at the Front and Back of Polarized Neutrophils* , 2013, The Journal of Biological Chemistry.

[24]  E. Vizi,et al.  CD39 and CD73 in immunity and inflammation. , 2013, Trends in molecular medicine.

[25]  Kevin J. Tracey,et al.  Sepsis definitions: time for change , 2013, The Lancet.

[26]  R. Hotchkiss,et al.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. , 2013, The Lancet. Infectious diseases.

[27]  M. Sitkovsky,et al.  Purinergic signaling during inflammation. , 2012, The New England journal of medicine.

[28]  D. Ojcius,et al.  Role of extracellular nucleotides in the immune response against intracellular bacteria and protozoan parasites. , 2012, Microbes and infection.

[29]  W. Junger,et al.  ATP release and autocrine signaling through P2X4 receptors regulate γδ T cell activation , 2012, Journal of leukocyte biology.

[30]  J. G. van der Hoeven,et al.  How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo , 2012, Critical care medicine.

[31]  E. Bulger,et al.  Hypertonic resuscitation after severe injury: is it of benefit? , 2012, Advances in surgery.

[32]  F. Di Virgilio,et al.  Extracellular ATP Exerts Opposite Effects on Activated and Regulatory CD4+ T Cells via Purinergic P2 Receptor Activation , 2012, The Journal of Immunology.

[33]  U. Schenk,et al.  Purinergic P2X7 Receptor Drives T Cell Lineage Choice and Shapes Peripheral γδ Cells , 2012, The Journal of Immunology.

[34]  S. Denk,et al.  Role of Activated Neutrophils in Chest Trauma–Induced Septic Acute Lung Injury , 2012, Shock.

[35]  R. Wenzel,et al.  Septic shock--evaluating another failed treatment. , 2012, The New England journal of medicine.

[36]  J. Sleigh,et al.  Hypertonic Fluid Administration in Patients With Septic Shock: A Prospective Randomized Controlled Pilot Study , 2012, Shock.

[37]  J. Vincent,et al.  Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial , 2012, Critical Care.

[38]  R. Hotchkiss,et al.  Immunosuppression in patients who die of sepsis and multiple organ failure. , 2011, JAMA.

[39]  P. Ward.  Immunosuppression in sepsis. , 2011, JAMA.

[40]  W. Junger,et al.  Immune cell regulation by autocrine purinergic signalling , 2011, Nature Reviews Immunology.

[41]  O. Soehnlein,et al.  Contribution of Neutrophils to Acute Lung Injury , 2011, Molecular medicine.

[42]  B. Franke,et al.  Circulating adenosine increases during human experimental endotoxemia but blockade of its receptor does not influence the immune response and subsequent organ injury , 2011, Critical care.

[43]  W. Junger,et al.  Hypertonic stress regulates T cell function via pannexin‐1 hemichannels and P2X receptors , 2010, Journal of leukocyte biology.

[44]  F. Di Virgilio,et al.  The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation , 2010, Allergy.

[45]  P. Insel,et al.  Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. , 2010, Blood.

[46]  Michael R. Elliott,et al.  Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis , 2010, Nature.

[47]  A. Schwab,et al.  Autocrine Purinergic Receptor Signaling Is Essential for Macrophage Chemotaxis , 2010, Science Signaling.

[48]  W. Junger,et al.  Purinergic Signaling: A Fundamental Mechanism in Neutrophil Activation , 2010, Science Signaling.

[49]  B. Fredholm,et al.  The birth and postnatal development of purinergic signalling , 2010, Acta physiologica.

[50]  S. Colgan,et al.  Signaling through the A2B Adenosine Receptor Dampens Endotoxin-Induced Acute Lung Injury , 2010, The Journal of Immunology.

[51]  Y. Moriyama,et al.  Involvement of SLC17A9-dependent Vesicular Exocytosis in the Mechanism of ATP Release during T Cell Activation , 2010, The Journal of Biological Chemistry.

[52]  Fei Wang.  The signaling mechanisms underlying cell polarity and chemotaxis. , 2009, Cold Spring Harbor perspectives in biology.

[53]  Michael R. Elliott,et al.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance , 2009, Nature.

[54]  R. Marée,et al.  P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation , 2009 .

[55]  P. Insel,et al.  Autocrine regulation of T‐cell activation by ATP release and P2X7 receptors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  S. Mohr,et al.  P2X7 Receptor-Stimulated Secretion of MHC Class II-Containing Exosomes Requires the ASC/NLRP3 Inflammasome but Is Independent of Caspase-1 1 , 2009, The Journal of Immunology.

[57]  F. Martinon,et al.  The inflammasomes: guardians of the body. , 2009, Annual review of immunology.

[58]  J. G. van der Hoeven,et al.  Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients * , 2009 .

[59]  Geoffrey Burnstock,et al.  Purinergic signalling in the nervous system: an overview , 2009, Trends in Neurosciences.

[60]  F. Cunha,et al.  THE ROLE OF NEUTROPHILS IN SEVERE SEPSIS , 2008, Shock.

[61]  J. Buer,et al.  Purinergic Control of T Cell Activation by ATP Released Through Pannexin-1 Hemichannels , 2008, Science Signaling.

[62]  A. Rubartelli,et al.  ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way , 2008, Proceedings of the National Academy of Sciences.

[63]  G. Yegutkin.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. , 2008, Biochimica et biophysica acta.

[64]  F. Di Virgilio,et al.  Liaisons dangereuses: P2X(7) and the inflammasome. , 2007, Trends in pharmacological sciences.

[65]  G. Dubyak,et al.  Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages1 , 2007, The Journal of Immunology.

[66]  V. Kuchroo,et al.  Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.

[67]  Linda Yip,et al.  ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors , 2006, Science.

[68]  S. Colgan,et al.  ATP Release From Activated Neutrophils Occurs via Connexin 43 and Modulates Adenosine-Dependent Endothelial Cell Function , 2006, Circulation research.

[69]  Jiang-Fan Chen,et al.  A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[70]  D. Ferrari,et al.  Shaping immune responses through the activation of dendritic cells–P2 receptors , 2006, Purinergic Signalling.

[71]  Pál Pacher,et al.  Adenosine receptors: therapeutic aspects for inflammatory and immune diseases , 2006, Nature Reviews Drug Discovery.

[72]  W. Law.  Adenosine receptors in the response to sepsis: what do receptor-specific knockouts tell us? , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[73]  C. Ledent,et al.  Adenosine A2A Receptor Inactivation Increases Survival in Polymicrobial Sepsis1 , 2006, The Journal of Immunology.

[74]  E. Vizi,et al.  Adenosine Augments IL-10 Production by Macrophages through an A2B Receptor-Mediated Posttranscriptional Mechanism1 , 2005, The Journal of Immunology.

[75]  Z. Ge,et al.  Adenosine Inhibits Tumor Necrosis Factor-α Release from Mouse Peritoneal Macrophages via A2A and A2B but Not the A3 Adenosine Receptor , 2005, Journal of Pharmacology and Experimental Therapeutics.

[76]  K. Heeg,et al.  “Host Tissue Damage” Signal ATP Promotes Non-directional Migration and Negatively Regulates Toll-like Receptor Signaling in Human Monocytes* , 2005, Journal of Biological Chemistry.

[77]  H. Lee,et al.  A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis. , 2005, AJP - Renal Physiology.

[78]  J. Oppenheim,et al.  Alarmins: chemotactic activators of immune responses. , 2005, Current opinion in immunology.

[79]  Courtney M. Lappas,et al.  A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells1 , 2005, The Journal of Immunology.

[80]  P. Insel,et al.  A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors , 2004, Journal of leukocyte biology.

[81]  J. Linden,et al.  A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. , 2004, The Journal of infectious diseases.

[82]  G. Dubyak,et al.  Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. , 2004, American journal of physiology. Cell physiology.

[83]  Jingsong Xu,et al.  Divergent Signals and Cytoskeletal Assemblies Regulate Self-Organizing Polarity in Neutrophils , 2003, Cell.

[84]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[85]  S. Opal,et al.  Endotoxin as a drug target , 2003, Critical care medicine.

[86]  W. Junger,et al.  Hypertonicity increases cAMP in PMN and blocks oxidative burst by PKA-dependent and -independent mechanisms. , 2002, American journal of physiology. Cell physiology.

[87]  A. Ohta,et al.  Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage , 2001, Nature.

[88]  R. Guieu,et al.  High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock , 2000, Critical care medicine.

[89]  H. Zimmermann.  Extracellular metabolism of ATP and other nucleotides , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[90]  D. Millhorn,et al.  Chronic Hypoxia Enhances Adenosine Release in Rat PC12 Cells by Altering Adenosine Metabolism and Membrane Transport , 2000, Journal of neurochemistry.

[91]  G. Chrousos,et al.  Ligand-Activation of the Adenosine A2a Receptors Inhibits IL-12 Production by Human Monocytes , 2000, The Journal of Immunology.

[92]  F. Di Virgilio,et al.  Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. , 1999, Journal of immunology.

[93]  I. P. Chessell,et al.  Pharmacological characterization of ATP‐ and LPS‐induced IL‐1β release in human monocytes , 1999 .

[94]  Z. Ba,et al.  Salutary effects of ATP-MgCl2 on the depressed endothelium-dependent relaxation during hyperdynamic sepsis. , 1999, Critical care medicine.

[95]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[96]  H. Junger,et al.  Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. , 1998, The Journal of clinical investigation.

[97]  Steve Huang,et al.  Role of A2a Extracellular Adenosine Receptor-Mediated Signaling in Adenosine-Mediated Inhibition of T-Cell Activation and Expansion , 1997 .

[98]  M. Sitkovsky,et al.  Effects of extracellular ATP and adenosine on different thymocyte subsets: possible role of ATP-gated channels and G protein-coupled purinergic receptor. , 1997, Journal of immunology.

[99]  B. Fredholm.  Purines and neutrophil leukocytes. , 1997, General pharmacology.

[100]  F. Di Virgilio,et al.  An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. , 1996, Blood.

[101]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[102]  I. Chaudry,et al.  Magnesium‐adenosine triphosphate in the treatment of shock, ischemia, and sepsis , 1992, Critical care medicine.

[103]  I. Chaudry.  Use of ATP following Shock and Ischemia a , 1990, Annals of the New York Academy of Sciences.

[104]  M. Sitkovsky,et al.  Extracellular ATP in T-lymphocyte activation: possible role in effector functions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[105]  Christopher J. Czura,et al.  “Merinoff Symposium 2010: Sepsis”—Speaking with One Voice , 2011, Molecular medicine.

[106]  M. Bours,et al.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. , 2006, Pharmacology & therapeutics.

[107]  B. Lakatoš,et al.  ATP-induced apoptosis of thymocytes is mediated by activation of P2 X 7 receptor and involves de novo ceramide synthesis and mitochondria. , 2006, Biochimica et biophysica acta.

[108]  B. Cronstein.  Adenosine, an endogenous anti-inflammatory agent. , 1994, Journal of applied physiology.

[109]  I. Chaudry.  ATP-MgCl2 and liver blood flow following shock and ischemia. , 1989, Progress in clinical and biological research.

[110]  I. Chaudry.  Cellular energetics and ATP-MgCl2 therapy in sepsis. , 1984, The American journal of emergency medicine.

[111]  G. Sandberg,et al.  Cyclic AMP in freshly prepared thymocyte suspensions, Evidence for stimulation by endogenous adenosine. , 1978, Biochemical pharmacology.